Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Denis

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
International Journal of Oncology|June 6, 1998
Characterization, cloning and expression of the Tage4 gene, a member of the immunoglobulin superfamilyM G Denis
Translational Lung Cancer Research|November 14, 2025
Molecular minimal residual disease in resected non-small cell lung cancer: "flattening the curve"Marc G Denis
Revue De Pneumologie Clinique|July 23, 2011
[Searching for EGFR: current practices]M-G Denis
Canadian Journal of Physiology and Pharmacology|April 1, 1974
Effect of calcitonin on P uptake in epiphyseal cartilages of P-deficient ratsG Denis, A Kuczerpa
Revue Canadienne De Biologie|September 1, 1972
The effect of hyperammonemia on lymph flow and free water excretionG Denis, G Béland
Social Science & Medicine|January 1, 1975
Psychiatric patients and the "untreated" cases of epidemiological surveys: a comparative analysis of the self-conceptM Tousignant, G Denis
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 24, 2023
The use of minimal residual disease in thoracic oncology: Gaps between promises and the on-the-ground reality of daily practicePaul Hofman, Marc G Denis
Revue Canadienne De Biologie|June 1, 1974
Calcitonin hypersensitivity in healing rickets: evidence that phosphorus is the prime target of calcitoninA V Kuczerpa, G Denis
Cancer Management and Research|December 16, 2020
Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic <i>EGFR</i>-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent TreatmentsMarc G Denis, Jaafar Bennouna
Biotechniques|December 1, 1995
Qualitative low-level internal control for nested RT-PCRM G Denis, P Lustenberger
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
International Journal of Oncology|June 6, 1998
Characterization, cloning and expression of the Tage4 gene, a member of the immunoglobulin superfamilyM G Denis
Translational Lung Cancer Research|November 14, 2025
Molecular minimal residual disease in resected non-small cell lung cancer: "flattening the curve"Marc G Denis
Revue De Pneumologie Clinique|July 23, 2011
[Searching for EGFR: current practices]M-G Denis
Canadian Journal of Physiology and Pharmacology|April 1, 1974
Effect of calcitonin on P uptake in epiphyseal cartilages of P-deficient ratsG Denis, A Kuczerpa
Revue Canadienne De Biologie|September 1, 1972
The effect of hyperammonemia on lymph flow and free water excretionG Denis, G Béland
Social Science & Medicine|January 1, 1975
Psychiatric patients and the "untreated" cases of epidemiological surveys: a comparative analysis of the self-conceptM Tousignant, G Denis
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 24, 2023
The use of minimal residual disease in thoracic oncology: Gaps between promises and the on-the-ground reality of daily practicePaul Hofman, Marc G Denis
Revue Canadienne De Biologie|June 1, 1974
Calcitonin hypersensitivity in healing rickets: evidence that phosphorus is the prime target of calcitoninA V Kuczerpa, G Denis
Cancer Management and Research|December 16, 2020
Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic <i>EGFR</i>-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent TreatmentsMarc G Denis, Jaafar Bennouna
Biotechniques|December 1, 1995
Qualitative low-level internal control for nested RT-PCRM G Denis, P Lustenberger
Pageof 19